Copy Number Variation at 14q12 and Genomic Abnormalities in Cancer
Author Information
Author(s): Ilan Braude, Bisera Vukovic, Mona Prasad, Paula Marrano, Stefanie Turley, Dwayne Barber, Maria Zielenska, Jeremy A Squire
Primary Institution: University of Toronto
Hypothesis
Is copy number variation (CNV) at 14q12 associated with genomic abnormalities in neoplasia?
Conclusion
The study found that CNV14q12 is more prevalent in tumor samples, suggesting a link to neoplasia.
Supporting Evidence
- CNV14q12 was found in ~50% of both tumor and CML DNA samples.
- 72% of CML patients with a der(9) microdeletion had CNV14q12.
- Statistical analysis showed a significant difference in CNV incidence between cancer and normal DNA.
Takeaway
Scientists looked at a specific part of DNA that changes in cancer and found it happens a lot in tumors, which might mean it helps cancer grow.
Methodology
The study used microarray comparative genomic hybridization (aCGH) and real-time polymerase chain reaction (Q-PCR) to analyze DNA samples from CML patients and pediatric tumors.
Limitations
The small sample size limited detailed statistical analysis of subsets within the study group.
Participant Demographics
The study included 19 cytogenetically normal samples and 24 CML patient samples, with a mix of ethnic backgrounds.
Statistical Information
P-Value
p ≤ 0.001
Statistical Significance
p ≤ 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website